bioRxiv Science⌕ Search

Biology subjects

Korth, K. M.

Publications and source records attributed to Korth, K. M..

2 recordsLinked to original sources

Estrous phase during fear extinction modulates fear relapse through a nigrostriatal dopamine pathway

Elevated ovarian hormones during fear extinction can enhance fear extinction memory retention and reduce renewal, but the mechanisms remain unknown. Ovarian hormones modulate dopamine (DA) transmission, a key player in fear extinction. In males, stimulation of substantia nigra (SN) DA neurons during fear extinction reduces renewal; an effect mimicked by a DA D1 receptor agonist into the dorsolateral striatum (DLS). The current studies tested the role of the SN-DLS pathway in estrous cycle-modulation of fear extinction and relapse. In cycling female, Long-Evans rats, fear extinction during proestrus or estrus (Pro/Est; high hormones) resulted in less relapse (renewal and spontaneous recovery) compared to males or females in metestrus or diestrus (Met/Di; low hormones). This effect was mimicked by estradiol (E2) administration to ovariectomized rats. Females in Pro/Est had greater fear extinction-induced cFos within SN DA neurons compared to males. Similarly, fast scan cyclic voltammetry revealed that electrically-evoked DA release in the DLS is potentiated by E2 and is greater during Pro/Est compared to Met/Di. An inhibitory intersectional chemogenetic approach targeting the SN-DLS pathway suppressed electrically-evoked DA release in the DLS and restored fear renewal in females exposed to simultaneous fear extinction and SN-DLS inhibition during Pro/Est. Conversely, chemogenetic stimulation of the SN-DLS pathway during extinction reduced fear renewal in males. These data suggest that levels of ovarian hormones present during fear extinction modulate relapse through a SN-DLS pathway, and that the SN-DLS pathway represents a novel target for the reduction of fear relapse in both sexes.

neuroscience↗

Fetal cannabidiol (CBD) exposure alters thermal pain sensitivity, cognition, and prefrontal cortex excitability

Thousands of people suffer from nausea with pregnancy each year. Nausea can be alleviated with cannabidiol (CBD), a primary component of cannabis that is widely available. However, is it unknown how fetal CBD exposure affects embryonic development and postnatal outcomes. CBD binds and activates receptors that are important for fetal development and are expressed in the fetal brain, including serotonin receptors (5HT1A), voltage-gated potassium (Kv)7 receptors, and the transient potential vanilloid 1 receptor (TRPV1). Excessive activation of each of these receptors during fetal development can disrupt neurodevelopment. Here, we test the hypothesis that intrauterine CBD exposure alters offspring neurodevelopment and postnatal behavior. We show that fetal CBD exposure sensitizes male offspring to thermal pain in a TRPV1 dependent manner. We show that fetal CBD exposure decreases cognitive function in female CBD-exposed offspring. We demonstrate that fetal CBD exposure increases the minimum current required to elicit action potentials and decreases the number of action potentials in female offspring layer 2/3 prefrontal cortex (PFC) pyramidal neurons. Fetal CBD exposure reduces the amplitude of glutamate uncaging-evoked excitatory post-synaptic currents. Combined, these data show that fetal CBD exposure disrupts neurodevelopment and postnatal behavior in a sex-dependent manner. One Sentence SummaryCannabidiol (CBD) consumption during pregnancy alters offspring behavior and neuronal excitability in a sex dependent manner in mice.

animal behavior and cognition↗